AccuVein to Demonstrate Its True Center™ Technology and Sponsor Workshop at AVA 2022

Medford, NY –(Business Wire)–AccuVein Inc., a global leader in near-infrared (NIR) vein visualization, today announced that it will showcase its innovative vein visualization device, AccuVein® The AV500 features its patented “True Center™” technology during this year’s Vascular Access Association (AVA2022) annual scientific meeting, held at the Minneapolis Convention Center from Friday, September 30 to Monday, October 3. AVA attendees can also visit AccuVein’s booth #914 to learn more about its robust education/training program.

The AV500’s True Center™ technology enables clinicians to accurately view the centerline of a vein, regardless of distance.Unlike other intravenous lighting devices, the AV500 is permanently aligned and requires no calibration of the device before use. There is currently no other NIR vein visualization device on the market that offers these unique technological advancements.

Additionally, AccuVein will be sponsoring AVA’s breakfast seminar titled “Stop Blindness and Gain NIR Sight” on Saturday, October 1st, from 7:00 am to 8:30 am ET in Room 101D. Leading experts in the field of peripheral IV pathways who will lead workshop discussions include Nancy Moureau, RN, PhD, CRNI, CPUI, VA-BC, Gregory Schears, MD and Charlotte Hart, DNP(c), MSN, RN, CNE, VA- BC.

The main learning objectives of this meeting are:

  • Discuss why blind rods for peripheral venous catheters are not best practice for venous access.

  • Describe how NIR vein visualization simplifies workflow and identifies more vein targets than can be palpated or seen with the naked eye.

  • Demonstrate how NIR vein visualization can help reduce adhesions, thereby reducing patient pain and keeping blood vessels healthy.

To learn more about this conference and to register, click here. Participants will receive 1.0 CE credit. For more information on how NIR vein visualization technology can help eliminate blind sticks, visit our booth.

“I am a strong advocate for eliminating the need for blind needling in clinical practice,” said Charlotte Hart, head of VAT. “We use AccuVein’s NIR Vein Visualization System in our practice every day and it is a true ‘game changer’. We have incorporated AccuVein into our PIV policy as a vascular assessment tool prior to each PIV placement and to assist with insertion .Thanks to its pinpoint accuracy, it allows us to perform PIV visit procedures more effectively and confidently. It helps us win back precious nursing time and reduces our overall stress and anxiety. Equally important, we Clinical outcomes have been significantly improved because we don’t have to make multiple acupuncture attempts on the vast majority of patients.”

Up to 90% of patients receive IV therapy at some point during their hospital stay, making it the most invasive medical procedure performed in the United States and globally. Although this is a routine procedure, venipuncture can be technically challenging. When multiple attempts at intravenous access are required, it increases patient morbidity, as well as increased utilization of staff and medical supplies.

“Initiating a peripheral intravenous (PIV) catheter is the most common invasive procedure in healthcare. Our mission is to improve the standard of care related to peripheral venous assessment and access so that PIV placement is as safe, effective, and efficient as possible and cost-effective,” said Thomas Hopkins, chief medical officer of AccuVein Inc. “We are extremely proud and committed to providing our healthcare heroes with the latest advancements in NIR vein visualization technology. To further underscore our commitment to clinicians, we are now offering bespoke training and educational support to increase confidence at the bedside and capacity, and help healthcare delivery teams recruit new employees,” Hopkins added.

About AccuVein Inc.

AccuVein Inc. is a pioneer in developing novel medical technologies that enable health professionals to improve vein assessment and maintain vascular health. The company has developed the only patented, eye-safe, laser-based device, the AV500, that uses near-infrared (NIR) technology to help clinicians see superficial veins, valves, and bifurcations for better-informed and accurate decisions needle/catheter placement. AccuVein is used in more than 5,000 facilities and is available in more than 130 countries around the world. To view a hands-on demonstration of the AccuVein AV500 and learn more about the unique benefits of the AccuVein Vein Visualization System, visit here.

Source link